Cargando…

Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection

Detalles Bibliográficos
Autores principales:	Kang, Sung Woon, Kim, Ji Yeun, Park, Heedo, Lim, So Yun, Kim, Jeonghun, Bae, Seongman, Jung, Jiwon, Kim, Min Jae, Chong, Yong Pil, Lee, Sang-Oh, Choi, Sang-Ho, Kim, Yang Soo, Park, Man-Seong, Kim, Sung-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188485/ https://www.ncbi.nlm.nih.gov/pubmed/35705135 http://dx.doi.org/10.1016/j.jinf.2022.06.002

Ejemplares similares

Corrigendum to “Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection” [J Infect 85 (2022) e69–e71]
por: Kang, Sung Woon, et al.
Publicado: (2023)

Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
por: Jung, Jiwon, et al.
Publicado: (2022)

Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19
por: Bae, Seongman, et al.
Publicado: (2022)

Clinical scoring system to predict viable viral shedding in patients with COVID-19
por: Kang, Sung Woon, et al.
Publicado: (2022)

Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient
por: Jung, Jiwon, et al.
Publicado: (2022)

Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

259. Comparison of the causes of death in patients with delta variant versus omicron variant infections
por: Reum Kim, A, et al.
Publicado: (2022)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
por: Kim, A Reum, et al.
Publicado: (2023)

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

288. Analysis of serum antibody response as correlates of protection against SARS-CoV-2 infection and the effects of BA.4/5 bivalent booster vaccination
por: Yun Lim, So, et al.
Publicado: (2023)

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Breakthrough infections and waning immune responses with ChAdOx1 nCoV‐19 or mRNA vaccine in healthcare workers
por: Lim, So Yun, et al.
Publicado: (2022)

Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
por: Park, Heedo, et al.
Publicado: (2022)

Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19
por: Cha, Hye Hee, et al.
Publicado: (2022)

Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19
por: Bae, Seongman, et al.
Publicado: (2021)

785. Bacterial Co-infection and Empirical Antibiotic Therapy in Patients with COVID-19
por: Lee, Jiyoung, et al.
Publicado: (2022)

Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19
por: Kim, Ji Yeun, et al.
Publicado: (2022)

Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19
por: Kim, Ji Yeun, et al.
Publicado: (2022)

Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

In Vitro Activities of Ceftazidime–Avibactam and Aztreonam–Avibactam at Different Inoculum Sizes of Extended-Spectrum β-Lactam-Resistant Enterobacterales Blood Isolates
por: Bae, Moonsuk, et al.
Publicado: (2021)

Risk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2021)

411. Comparison of clinical outcomes between early and delayed transplantation after SARS-CoV-2 infection
por: Reum Kim, A, et al.
Publicado: (2023)

Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing
por: Chang, Euijin, et al.
Publicado: (2023)

Transmission Characteristics of SARS-CoV-2 That Hinder Effective Control
por: Bae, Seongman, et al.
Publicado: (2021)

61. Short- versus prolonged-courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection
por: Bae, Moonsuk, et al.
Publicado: (2021)

The Immune Correlates of Orthohantavirus Vaccine
por: Bae, Joon-Yong, et al.
Publicado: (2021)

Clinical Sensitivity of the (1–3)-β-D-glucan Test for Predicting Candidemia
por: Lee, Yun Woo, et al.
Publicado: (2023)

Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19
por: Lee, Jiyoung, et al.
Publicado: (2023)

Clinical characteristics of COVID-19 rebound after nirmatrelvir-ritonavir or molnupiravir therapy: A prospective cohort study
por: Han, Jaijun, et al.
Publicado: (2023)

Risk and Outcome of Infective Endocarditis in Streptococcal Bloodstream Infections according to Streptococcal Species
por: Seo, Hyeonji, et al.
Publicado: (2023)

515. The Impact of Prolonged Steroid Use on Critically Ill COVID-19 Patients: A Retrospective Cohort Study
por: Han, Jaijun, et al.
Publicado: (2023)

Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
por: Shin, Yura, et al.
Publicado: (2022)

Comparison of Waning Immunity Between Booster Vaccination and 2-Dose Vaccination With BNT162b2
por: Jung, Jiwon, et al.
Publicado: (2022)

Clinical impact of and microbiological risk factors for qacA/B positivity in ICU-acquired ST5-methicillin-resistant SCCmec type II Staphylococcus aureus bacteremia
por: Kim, Haein, et al.
Publicado: (2022)

Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
por: Seo, Hyeonji, et al.
Publicado: (2022)

Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study
por: Bae, Seongman, et al.
Publicado: (2021)

Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
por: Shin, Yura, et al.
Publicado: (2022)

Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination
por: Lim, So Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_riusdhuc1seg1qkk03vegu575e